Document Detail

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein.
MedLine Citation:
PMID:  10652158     Owner:  NLM     Status:  MEDLINE    
Mutations in the tumour suppressor gene p53 are among the most frequent genetic alterations in human malignancies, often associated with an accumulation of the p53 protein in the cytoplasm. We have generated a number of cytotoxic T lymphocyte (CTL) clones that specifically recognize the HLA-A*0201 p53 wild type peptide RMPEAAPPV [65-73], designated R9V, by the in vitro stimulation of CD8 enriched peripheral blood lymphocytes from a healthy HLA-A*0201 donor using peptide loaded autologous dendritic cells. A total of 22 CTL clones were generated from the same bulk culture and demonstrated to carry identical T-cell receptors. The CTL clone, 2D9, was shown to specifically lyse the HLA-A*0201+ squamous carcinoma cell line SCC9 and the breast cancer cell line MDA-MB-468. Our data demonstrate that human peripheral blood lymphocytes from normal healthy individuals comprise T cells capable of recognizing p53 derived wild type (self) peptides. Furthermore, the capacity of R9V specific T cell clones to exert HLA restricted cytotoxicity, argues that the R9V peptide is naturally presented on certain cancer cells. This supports the view that p53 derived wild type peptides might serve as candidate target antigens for the immunotherapeutic treatment of cancer.
A M Barfoed; T R Petersen; A F Kirkin; P Thor Straten; M H Claesson; J Zeuthen
Related Documents :
11309698 - Cell function-based flow cytometry.
9034138 - Induction of apoptosis and t helper 2 (th2) responses correlates with peptide affinity ...
12819078 - Identification of cd8 t-lymphocyte epitopes in ompb of rickettsia conorii.
11602708 - Recruitment times, proliferation, and apoptosis rates during the cd8(+) t-cell response...
18354038 - Tumor-specific th17-polarized cells eradicate large established melanoma.
7537118 - Role of b7-1 in mediating an immune response to myeloid leukemia cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Scandinavian journal of immunology     Volume:  51     ISSN:  0300-9475     ISO Abbreviation:  Scand. J. Immunol.     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-03-15     Completed Date:  2000-03-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0323767     Medline TA:  Scand J Immunol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  128-33     Citation Subset:  IM    
Department of Tumour Cell Biology, Institute of Cancer Biology, Danish Cancer Society, DK-2100 Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Line, Transformed
Cells, Cultured
Clone Cells
Coculture Techniques
Cytotoxicity, Immunologic / immunology
Dendritic Cells / immunology*
Gene Expression
HLA-A2 Antigen / immunology*
K562 Cells
Peptides / immunology,  metabolism
Receptors, Antigen, T-Cell / genetics
T-Lymphocytes, Cytotoxic / cytology,  immunology*
Tumor Cells, Cultured
Tumor Suppressor Protein p53 / biosynthesis,  genetics,  immunology*
Reg. No./Substance:
0/HLA-A2 Antigen; 0/Peptides; 0/Receptors, Antigen, T-Cell; 0/Tumor Suppressor Protein p53

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity...
Next Document:  Recognition of auto- and exoantigens by V4-34 gene encoded antibodies.